中/EN: 中文繁體 English

Investor Relations
IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
Corporate

Press Releases

2017

Please select

AUG
24

The United Laboratories International Holdings Limited Recorded A Turnaround with Profit in 2017 Interim Results, Maintained Outstanding Sales Performance of Recombinant Human Insulin Injection Products Officially Launched Insulin Glargine Injection to Drive Sales Growth in the Future

MAY
14

"United Laboratories USLEN" Insulin Glargin Gained Experts' Recognition and Recommendation, Successfully Won the Tender Through Bidding in Four China Provinces and Products are to be Rolled Out Gradually

MAR
23

The United Laboratories International Holdings Limited Announces 2016 Annual Results, Maintained Outstanding Performance of Recombinant Human Insulin Injection Products, Gained Approval to Produce Insulin Glargine for Injection and Drive Sales in the Future